Tempest Therapeutics, Inc. (TPST)
NASDAQ: TPST · Real-Time Price · USD
1.020
-0.030 (-2.86%)
Sep 4, 2026, 1:19 PM EDT - Market open
Tempest Therapeutics Market Cap
Tempest Therapeutics has a market cap or net worth of $16.3 million as of September 4, 2026. Its market cap has decreased by -63.00% in one year.
Market Cap
16.30M
Enterprise Value
23.08M
1-Year Change
-63.00%
Ranking
Category
Stock Price
$1.02
ChartMarket Cap Chart
Since June 28, 2021, Tempest Therapeutics's market cap has decreased from $88.65M to $16.30M, a decrease of -81.61%. That is a compound annual growth rate of -27.87%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 2, 2026 | 17.58M | 24.30% |
| Dec 31, 2025 | 14.14M | -61.17% |
| Dec 31, 2024 | 36.42M | -57.00% |
| Dec 29, 2023 | 84.69M | 600.22% |
| Dec 30, 2022 | 12.09M | -66.85% |
| Dec 31, 2021 | 36.49M | -58.84% |
| Jun 28, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Dyadic International | 18.24M |
| Adial Pharmaceuticals | 17.49M |
| Psyence Biomedical | 16.90M |
| Citius Pharmaceuticals | 16.53M |
| BioCardia | 16.50M |
| Quoin Pharmaceuticals | 15.81M |
| Vyome Holdings | 15.65M |
| BioVie | 15.31M |